Patent · US Active

MET receptor agonist proteins

US10435450B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 21, 2016
Grant dateOct 8, 2019
Priority date
Expiry dateJan 21, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/75
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are proteins derived from the HGF/SF which are able to induce activation of the tyrosine kinase receptor MET and their uses, in particular to promote tissue regeneration. Further disclosed are nucleic acid molecules coding such protein, expression vectors containing such nucleic acid molecule, host cells containing such expression vectors, and related compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.